I am very disappointed. My prediction that the costs will far outweigh the revenue was correct. Total costs of almost a whopping 4 millions against a revenue of just above 2 millions dollars is disturbing. This way the company will never be profitable. I have always said that the management needs to respect money but this culture or warning is never taken seriously.
Unless the management seriously sits down and start looking at ways of reducing costs and takes cost reduction as their number one priority and stops behaving as if it is a billion dollar entity, we are heading towards a total insolvency.
- Forums
- ASX - By Stock
- AN1
- Ann: Appendix 4C and Notes to Appendix 4C
Ann: Appendix 4C and Notes to Appendix 4C, page-6
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online